FINDEX Inc. (TYO:3649)
858.00
+1.00 (0.12%)
Aug 21, 2025, 3:30 PM JST
FINDEX Revenue
FINDEX had revenue of 1.17B JPY in the quarter ending June 30, 2025, with 8.60% growth. This brings the company's revenue in the last twelve months to 5.76B, down -6.27% year-over-year. In the year 2024, FINDEX had annual revenue of 5.84B with 12.52% growth.
Revenue (ttm)
5.76B
Revenue Growth
-6.27%
P/S Ratio
3.73
Revenue / Employee
18.52M
Employees
311
Market Cap
21.49B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.84B | 650.00M | 12.52% |
Dec 31, 2023 | 5.19B | 650.00M | 14.31% |
Dec 31, 2022 | 4.54B | -427.00M | -8.60% |
Dec 31, 2021 | 4.97B | 964.00M | 24.08% |
Dec 31, 2020 | 4.00B | -277.00M | -6.47% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.22B |
Takeda Pharmaceutical Company | 4,480.25B |
Daiichi Sankyo Company | 1,924.68B |
HOYA Corporation | 876.09B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |